Q1 FY27 snapshot
Announcement Date31-Jul-26
Revenue (Top Line)₹426 Cr
Net Profit (Bottom Line)₹60 Cr
Earnings Per Share (EPS)₹9.83
Expenses₹365 Cr
Net profit margin (calculated)14.1%
Corona Remedies Ltd. (CORONA) Quarterly Results: Q1 FY27
Quick answer: Corona Remedies Ltd. (NSE: CORONA) reported Q1 FY27 revenue of ₹426 Cr and net profit of ₹60 Cr, with earnings per share (EPS) of ₹9.83, announced on 31-Jul-26.
That works out to a net profit margin of about 14.1% for the quarter.
Note: figures are pulled automatically from company filings and may lag or contain gaps. Verify on NSE or BSE. Not investment advice.
How to read Corona Remedies Ltd.'s Q1 FY27 results
Revenue of ₹426 Cr is what Corona Remedies Ltd. earned before costs. Net profit of ₹60 Cr is what remained for shareholders after expenses, interest and tax. Dividing one by the other gives a net margin of about 14.1%, a quick gauge of how much of each rupee of sales is kept as profit.
New to results? Read our guide on how to read quarterly results, see the full results list or the dividend calendar.
FAQs
Corona Remedies Ltd. results FAQs
What were Corona Remedies Ltd.'s Q1 FY27 results?
Corona Remedies Ltd. (NSE: CORONA) reported Q1 FY27 revenue of ₹426 Cr and net profit of ₹60 Cr, with earnings per share (EPS) of ₹9.83, announced on 31-Jul-26.
What is Corona Remedies Ltd.'s EPS for Q1 FY27?
Corona Remedies Ltd.'s earnings per share for Q1 FY27 was ₹9.83. EPS is net profit divided by the number of outstanding shares.
When did Corona Remedies Ltd. announce its Q1 FY27 results?
Corona Remedies Ltd. announced its Q1 FY27 results on 31-Jul-26.
What is Corona Remedies Ltd.'s net profit margin?
On the reported figures, Corona Remedies Ltd.'s Q1 FY27 net profit margin is about 14.1% (net profit ÷ revenue).